Simone Birch

Brisbane, QLD, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma.

Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma.

Journal: American journal of hematology

Published: June 10, 2024

Preoperative breast MR imaging influences surgical management in patients with invasive lobular carcinoma.

Preoperative breast MR imaging influences surgical management in patients with invasive lobular carcinoma.

Journal: Journal of medical imaging and radiation oncology

Published: April 22, 2024

An unnatural hepatic infiltrate: a rare case of extranodal NK/T-cell lymphoma, nasal type, presenting with recurrent ascites.

An unnatural hepatic infiltrate: a rare case of extranodal NK/T-cell lymphoma, nasal type, presenting with recurrent ascites.

Journal: Internal medicine journal

Published: September 07, 2021

Genetic aberrations of NLRC5 are associated with downregulated MHC-I antigen presentation and impaired T-cell immunity in follicular lymphoma.

Genetic aberrations of NLRC5 are associated with downregulated MHC-I antigen presentation and impaired T-cell immunity in follicular lymphoma.

Journal: EJHaem

Published: August 25, 2020

LAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma.

LAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma.

Journal: Blood advances

Published: January 15, 2020

Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration.

Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 29, 2019

The tumour microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV-positive diffuse large B-cell lymphoma.

The tumour microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV-positive diffuse large B-cell lymphoma.

Journal: European journal of haematology

Published: March 18, 2019

COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study.

COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study.

Journal: Blood advances

Published: January 15, 2019

An analysis of a multiple biomarker panel to better predict prostate cancer metastasis after radical prostatectomy.

An analysis of a multiple biomarker panel to better predict prostate cancer metastasis after radical prostatectomy.

Journal: International journal of cancer

Published: June 28, 2018

Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL.

Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL.

Journal: Blood

Published: July 13, 2017

The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma.

The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 23, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026